Symbol="FRLN"
AssetType="Common Stock"
Name="Freeline TherapeuticsÂ Holdings Plc"
Description="Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops vector-mediated adeno-associated virus (AAV) transforming gene therapies for patients suffering from inherited systemic debilitating diseases. The company is headquartered in Stevenage, the United Kingdom."
CIK="1810031"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="STEVENAGE BIOSCIENCE CATALYST, GUNNELS WOOD ROAD, STEVENAGE, HERTFORDSHIRE, GB"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="17808500"
EBITDA="-84667000"
PERatio="None"
PEGRatio="None"
BookValue="12.89"
DividendPerShare="0"
DividendYield="0"
EPS="-11.02"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.388"
ReturnOnEquityTTM="-0.7"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-11.02"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="12.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.559"
EVToRevenue="-"
EVToEBITDA="0.146"
Beta="0.707"
num_52WeekHigh="14.7"
num_52WeekLow="2.11"
num_50DayMovingAverage="3.442"
num_200DayMovingAverage="6.37"
SharesOutstanding="4343500"
DividendDate="None"
ExDividendDate="None"
symbol="FRLN"
open="4.01"
high="4.07"
low="3.74"
price="3.86"
volume="32260.00"
latest_trading_day="2023-08-15"
previous_close="4.10"
change="-0.24"
change_percent="-5.8537%"
aroon_positive_momentum_days="25"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="25"
Volume_recent_avg="326142"
Change_recent_avg="0.01"
Delta_recent_avg="0.36"
Variance_recent_avg="0.18"
Change_ratio_recent_avg="-1.53"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="25"
Aroon_momentum_negative="75"
image_negative_thumbnail_id_1="498"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0107.jpeg"
image_negative_thumbnail_id_2="1092"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0125.jpeg"
image_neutral_thumbnail_id_1="553"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_neutral_thumbnail_id_2="527"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_positive_thumbnail_id_1="658"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0050.jpeg"
image_positive_thumbnail_id_2="1003"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0165.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
